Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Feb 6;5(11):a017889.
doi: 10.1101/cshperspect.a017889.

Tuberculosis Comorbidity with Communicable and Noncommunicable Diseases

Affiliations
Review

Tuberculosis Comorbidity with Communicable and Noncommunicable Diseases

Matthew Bates et al. Cold Spring Harb Perspect Med. .

Abstract

The 18th WHO Global Tuberculosis Annual Report indicates that there were an estimated 8.6 million incident cases of tuberculosis (TB) in 2012, which included 2.9 million women and 530,000 children. TB caused 1.3 million deaths including 320,000 human immunodeficiency virus (HIV)-infected people; three-quarters of deaths occurred in Africa and Southeast Asia. With one-third of the world's population latently infected with Mycobacterium tuberculosis (Mtb), active TB disease is primarily associated with a break down in immune surveillance. This explains the strong link between active TB disease and other communicable diseases (CDs) or noncommunicable diseases (NCDs) that exert a toll on the immune system. Comorbid NCD risk factors include diabetes, smoking, malnutrition, and chronic lung disease, all of which have increased relentlessly over the past decade in developing countries. The huge overlap between killer infections such as TB, HIV, malaria, and severe viral infections with NCDs, results in a "double burden of disease" in developing countries. The current focus on vertical disease programs fails to recognize comorbidities or to encourage joint management approaches. This review highlights major disease overlaps and discusses the rationale for better integration of tuberculosis care with services for NCDs and other infectious diseases to enhance the overall efficiency of the public health responses.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Estimates of population attributable to TB disease risk caused by HIV, undernutrition, smoking, diabetes, and alcohol abuse. AFR high HIV: African countries with high HIV prevalence. AFR low HIV: African countries with low/moderate HIV prevalence. CEUR: Central European countries. EEUR: Eastern European countries. EME: Established market economies. EMR: Eastern Mediterranean region. LAC: Latin American countries. SEAR: Southeast Asian region. WPR: Western Pacific region (except EME). Population attributable fraction (PAF) = [prevalence × (relative risk − 1)]/[prevalence × (relative risk − 1) + 1]. Point estimates of relative risk from systematic reviews were used. When prevalence was only available for adults, the prevalence in adults was adjusted for proportion of population under the age of 15 to estimate the total population PAF. HIV (human immunodeficiency virus infection): Relative risk = 27. Undernourishment (undernutrition): Relative risk = 3.2 (for BMI 16 vs. BMI 25). Diabetes (DM, diabetes mellitus): Relative risk = 3.1. Alcohol abuse: Relative risk = 2.9. Prevalence data: Average of prevalence of heavy drinking in China, Brazil, India, Nigeria, Pakistan, Russia, South Africa, and Thailand. Smoking (cigarette smoking): Relative risk = 2.0 (current vs. never smokers). (Adapted from Lönnroth et al. 2010 and Creswell et al. 2011.)

Similar articles

Cited by

References

    1. Adeyi OSO, Robles S. 2007. Public policy and the challenge of chronic noncommunicable diseases. World Bank, Washington, DC.
    1. Adhikari M, Jeena P, Bobat R, Archary M, Naidoo K, Coutsoudis A, Singh R, Nair N. 2011. HIV-associated tuberculosis in the newborn and young infant. Int J Pediatr 2011: 354208. - PMC - PubMed
    1. Alisjahbana B, Sahiratmadja E, Nelwan EJ, Purwa AM, Ahmad Y, Ottenhoff TH, Nelwan RH, Parwati I, van der Meer JW, van Crevel R. 2007. The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Infect Dis 45: 428–435. - PubMed
    1. Archer B, Cohen C, Naidoo D, Thomas J, Makunga C, Blumberg L, Venter M, Timothy G, Puren A, McAnerney J, et al. 2009. Interim report on pandemic H1N1 influenza virus infections in South Africa, April to October 2009: Epidemiology and factors associated with fatal cases. Euro Surveill 14: 19369. - PubMed
    1. Arentz M, Pavlinac P, Kimerling ME, Horne DJ, Falzon D, Schunemann HJ, Royce S, Dheda K, Walson JL, group ARTs. 2012. Use of anti-retroviral therapy in tuberculosis patients on second-line anti-TB regimens: A systematic review. PloS ONE 7: e47370. - PMC - PubMed

Publication types